Patents by Inventor Steve Poon

Steve Poon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200298135
    Abstract: A model train track is provided that includes a plurality of track segments. Each track segment may include a roadbed, a plurality of rails, and a plurality of magnetic devices that are used to physically connect a track segment with an adjacent track segment. In other words, as two track segments move close to one another, the attraction between the magnetic devices on the two segments will not only pull the segments together, but, once connected, will maintain a physical connection therebetween until sufficient force is applied to overcome the magnetic attraction. Each track segment may also include at least one alignment portion, for aligning adjacent track segments during user assembly, and a plurality of contacts (e.g., biased or spring-loaded contacts) providing electrical continuity between adjacent track segments and components thereof (e.g., rails).
    Type: Application
    Filed: June 8, 2020
    Publication date: September 24, 2020
    Inventors: Steve Poon, Bob LaParl, David Olson
  • Publication number: 20060189682
    Abstract: Disclosed are water soluble compounds which are useful as prodrugs of COX-2 inhibitors, and pharmaceutical compositions comprising them.
    Type: Application
    Filed: February 2, 2006
    Publication date: August 24, 2006
    Inventors: Joseph Payne, Steve Poon, Nicholas Smith, Nicholas Stock, Angela McGuire
  • Publication number: 20050153986
    Abstract: Tetrazole compounds substituted directly, or by a bridge, with i) a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl and ii) another heteroaryl or aryl ring, with at least one of the rings being further substituted with another ring, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, panic, and bipolar disorder, as well as in the treatment of pain, Parkinson's disease, cognitive dysfunction, epilepsy, circadian rhythm disorders, drug addiction, drug abuse, drug withdrawal, obesity and other diseases.
    Type: Application
    Filed: March 7, 2003
    Publication date: July 14, 2005
    Inventors: Chixu Chen, Nicholas Cosford, Brian Eastman, Dehua Huang, Steve Poon, Thomas Reger, Jeffrey Roppe, Nicholas Smith